# Xolair becomes substitutable in pharmacies by its biosimilar Omlyclo

> Omalizumab (Xolair) becomes substitutable in pharmacies by its biosimilar Omlyclo, a change in how this treatment is dispensed.

**In brief**: Health event (severity: info) nationwide, first detected on 27 October 2026 at 15:27. Reported by 1 source (1 article), last updated on 27 October 2026 at 15:27.

- Category: Health
- Severity: Info
- Place: Nationwide
- First detected: 27 October 2026 at 15:27
- Updated: 27 October 2026 at 15:27
- Web page: https://acturadar.com/en/events/3393-xolair-becomes-substitutable-in-pharmacies-by-its-biosimilar-omlyclo

## Sources (1 articles)

- [Omalizumab : Xolair devient substituable en officine par son biosimilaire Omlyclo - Le Moniteur des pharmacies](https://news.google.com/rss/articles/CBMi8AFBVV95cUxQekpLanA4T2ljX3dZNTAzYm9oY1dqbmo4VlJ6X1pHRlcyajRWS19RbEozeWF5cGU3bTN4eHNobW5fMU1ubklyclI0eV9LZklmX2dkMVZHOFA4MTVSM1hlS3ljQ1FwekdZTUw5S2owY290VTJuMGZkZXcxel9zVWU1dmdBZ0ZlVGVxOWZVS3otOS0zektnWTdpMjJCZFg5Z3ZLclU4aHdRRmtVeFlGcC1rTVA0Q1lCTmpnQ04yVzhBUm9FRDdaWjY3Q0xMN0g5ZFVKY0dwb0g1bnJmbXJCaUJhVmR5SFRha2kxbUlRVmdiOFU?oc=5) — Le Moniteur des pharmacies, 27 October 2026 at 15:27

---

Cite as: Acturadar, “Xolair becomes substitutable in pharmacies by its biosimilar Omlyclo”, https://acturadar.com/en/events/3393-xolair-becomes-substitutable-in-pharmacies-by-its-biosimilar-omlyclo
Methodology: https://acturadar.com/en/methodology